Association between serum lactate levels and mortality in patients with cardiogenic shock receiving mechanical circulatory support: a multicenter retrospective cohort study

[1]  H. Thiele,et al.  Arterial Lactate in Cardiogenic Shock: Prognostic Value of Clearance Versus Single Values. , 2020, JACC. Cardiovascular interventions.

[2]  N. Kapur.  Faculty Opinions recommendation of Feasibility of early mechanical circulatory support in acute myocardial infarction complicated by cardiogenic shock: The Detroit cardiogenic shock initiative. , 2020, Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature.

[3]  Zhenghao Xu,et al.  Cytokine Storm in COVID-19: The Current Evidence and Treatment Strategies , 2020, Frontiers in Immunology.

[4]  D. Brodie,et al.  Temporary circulatory support for cardiogenic shock , 2020, The Lancet.

[5]  B. Gersh,et al.  Response to: Risk stratification for stroke in atrial fibrillation: incorporating neurologists in the comprehensive management. , 2019, European heart journal.

[6]  M. D'ayala,et al.  A Simple Scoring System to Predict Survival after Venoarterial Extracorporeal Membrane Oxygenation. , 2019, The journal of extra-corporeal technology.

[7]  H. Thiele,et al.  Management of cardiogenic shock complicating myocardial infarction: an update 2019. , 2019, European heart journal.

[8]  J. Ornato,et al.  SCAI clinical expert consensus statement on the classification of cardiogenic shock , 2019, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[9]  B. Pieske,et al.  Impella versus IABP in acute myocardial infarction complicated by cardiogenic shock , 2019, Open Heart.

[10]  G. Fuernau.  Lactate and other biomarkers as treatment target in cardiogenic shock. , 2019, Current opinion in critical care.

[11]  C. Di Mario,et al.  Trial protocol for the validation of the ‘Toronto Aortic Stenosis Quality of Life (TASQ) Questionnaire’ in patients undergoing surgical aortic valve replacement (SAVR) or transfemoral (TF) transcatheter aortic valve implantation (TAVI): the TASQ registry , 2019, Open Heart.

[12]  S. Felix,et al.  Real-world clinical experience with the percutaneous extracorporeal life support system: Results from the German Lifebridge® Registry , 2019, Clinical Research in Cardiology.

[13]  Michael V. Green,et al.  Improved Outcomes Associated with the use of Shock Protocols: Updates from the National Cardiogenic Shock Initiative , 2019, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[14]  L. Bang,et al.  Lactate is a Prognostic Factor in Patients Admitted With Suspected ST-Elevation Myocardial Infarction , 2019, Shock.

[15]  J. Bakker,et al.  Effect of a Resuscitation Strategy Targeting Peripheral Perfusion Status vs Serum Lactate Levels on 28-Day Mortality Among Patients With Septic Shock: The ANDROMEDA-SHOCK Randomized Clinical Trial , 2019, JAMA.

[16]  R. Lin,et al.  Blood Lactate as a Reliable Marker for Mortality of Pediatric Refractory Cardiogenic Shock Requiring Extracorporeal Membrane Oxygenation , 2019, Pediatric Cardiology.

[17]  Guangyou Duan,et al.  Effects of patient-controlled analgesia with hydromorphone or sufentanil on postoperative pulmonary complications in patients undergoing thoracic surgery: a quasi-experimental study , 2018, BMC Anesthesiology.

[18]  S. Turan,et al.  Does lactate clearance prognosticates outcomes in ECMO therapy: a retrospective observational study , 2018, BMC Anesthesiology.

[19]  Yixin Fang,et al.  Value of variation index of inferior vena cava diameter in predicting fluid responsiveness in patients with circulatory shock receiving mechanical ventilation: a systematic review and meta-analysis , 2018, Critical Care.

[20]  A. Chao,et al.  Investigation of microcirculation in patients with venoarterial extracorporeal membrane oxygenation life support , 2018, Critical Care.

[21]  K. Veien,et al.  Single-centre experience with the Impella CP, 5.0 and RP in 109 consecutive patients with profound cardiogenic shock , 2018, European heart journal. Acute cardiovascular care.

[22]  Yeong-Hoon Choi,et al.  Lactate and lactate clearance as valuable tool to evaluate ECMO therapy in cardiogenic shock , 2017, Journal of critical care.

[23]  B. Gencer,et al.  The peak of blood lactate during the first 24h predicts mortality in acute coronary syndrome patients under extracorporeal membrane oxygenation. , 2016, International journal of cardiology.

[24]  M. Lai,et al.  Survival Analysis After Extracorporeal Membrane Oxygenation in Critically Ill Adults: A Nationwide Cohort Study , 2016, Circulation.

[25]  P. Leprince,et al.  The ENCOURAGE mortality risk score and analysis of long-term outcomes after VA-ECMO for acute myocardial infarction with cardiogenic shock , 2016, Intensive Care Medicine.

[26]  B. Albat,et al.  Management and outcome of patients supported with Impella 5.0 for refractory cardiogenic shock , 2015, Critical Care.

[27]  Michael Bailey,et al.  Predicting survival after ECMO for refractory cardiogenic shock: the survival after veno-arterial-ECMO (SAVE)-score. , 2015, European heart journal.

[28]  X. Hou,et al.  The early dynamic behavior of lactate is linked to mortality in postcardiotomy patients with extracorporeal membrane oxygenation support: A retrospective observational study. , 2015, The Journal of thoracic and cardiovascular surgery.

[29]  D. Scotti,et al.  PERCUTANEOUS CARDIAC ASSIST DEVICES COMPARED WITH SURGICAL HEMODYNAMIC SUPPORT ALTERNATIVES: COST–EFFECTIVENESS IN THE EMERGENT SETTING , 2013 .

[30]  S. Cook,et al.  Percutaneous Left-Ventricular Support With the Impella-2.5–Assist Device in Acute Cardiogenic Shock: Results of the Impella–EUROSHOCK-Registry , 2013, Circulation. Heart failure.

[31]  A. Shpektor.  Cardiogenic shock: The role of inflammation , 2010, Acute cardiac care.

[32]  Peter Bauer,et al.  SAPS 3—From evaluation of the patient to evaluation of the intensive care unit. Part 2: Development of a prognostic model for hospital mortality at ICU admission , 2005, Intensive Care Medicine.

[33]  J. Vincent,et al.  Serial evaluation of the SOFA score to predict outcome in critically ill patients. , 2001, JAMA.

[34]  J. van der Linden,et al.  Venoarterial extracorporeal membrane oxygenation for postcardiotomy shock: Risk factors for mortality , 2018, The Journal of thoracic and cardiovascular surgery.

[35]  J. Vincent,et al.  Circulatory shock. , 2013, The New England journal of medicine.

[36]  Seung‐Jung Park,et al.  Long-term outcomes of percutaneous mitral balloon valvuloplasty versus open cardiac surgery. , 2010, Journal of Thoracic and Cardiovascular Surgery.

[37]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..

[38]  M. Weyand,et al.  MODULATING IL‐6 AND IL‐10 LEVELS BY PHARMACOLOGIC STRATEGIES AND THE IMPACT OF DIFFERENT EXTRACORPOREAL CIRCULATION PARAMETERS DURING CARDIAC SURGERY , 2001, Shock.